Oct 15, 201901:12 PMInside Wisconsin
with Tom Still
Injecting a dose of urgency: Clinical trials at UW Health get fresh approach
(page 2 of 2)
Nugent is part of an evolution within UW Health that is designed to speed “translational research,” which is shorthand for applying knowledge from basic biology and clinical trials to techniques and tools that address critical medical needs. With the nation’s only combined school of medicine and public health, 1,500 faculty, and $368 million per year in research from outside its walls, there’s no reason for the UW–Madison and its affiliates to miss the boat on clinical research.
“UW Health should really be a leader,” said Thomas “Rock” Mackie, a researcher and serial entrepreneur who recently became UW Health’s chief innovation officer. “This is a unique opportunity in academics … The rewards are not just financial, but reputational in terms of advancing human health.”
Nugent, Mackie, and Kurt Zimmerman, who will direct the Office of Industry Engagement within the medical school, form the core of what’s called the “Isthmus Project.” It draws its name from the concept of better connecting research, trials, and patient care. That will include working more closely with other medical institutions in Wisconsin and beyond.
Let’s hope this “isthmus” is a firm enough land mass to support researchers, innovative companies, and patients in need of proven solutions.
Click here to sign up for the free IB ezine — your twice-weekly resource for local business news, analysis, voices, and the names you need to know. If you are not already a subscriber to In Business magazine, be sure to sign up for our monthly print edition here.